Abstract
The integration of up- and downstream unit operations can result in the elimination of hold steps, thus decreasing the footprint, and ultimately can create robust closed system operations. This type of design is desirable for the bioprocess of human mesenchymal stem cells (hMSC), where high numbers of pure cells, at low volumes, need to be delivered for therapy applications. This study reports a proof of concept of the integration of a continuous perfusion culture in bioreactors with a tangential flow filtration (TFF) system for the concentration and washing of hMSC. Moreover, we have also explored a continuous alternative for concentrating hMSC. Results show that expanding cells in a continuous perfusion operation mode provided a higher expansion ratio, and led to a shift in cells' metabolism. TFF operated either in continuous or discontinuous allowed to concentrate cells, with high cell recovery (>80%) and viability (>95%); furthermore, continuous TFF permitted to operate longer with higher cell concentrations. Continuous diafiltration led to higher protein clearance (98%) with lower cell death, when comparing to discontinuous diafiltration. Overall, an integrated process allowed for a shorter process time, recovering 70% of ...Continue Reading
References
Jan 1, 1985·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·K H Jones, J A Senft
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 20, 2005·Stem Cells·Panagiota A SotiropoulouMichael Papamichail
Aug 23, 2005·Toxicology Letters·George Fotakis, John A Timbrell
Aug 23, 2006·Cytotherapy·M DominiciEm Horwitz
Mar 26, 2009·Regenerative Medicine·Chris Mason, Peter Dunnill
Oct 21, 2009·Journal of Tissue Engineering and Regenerative Medicine·D SchopJ D de Bruijn
Jul 6, 2010·Journal of Biotechnology·Margarida SerraPaula M Alves
Sep 3, 2010·Biotechnology and Bioengineering·Rui M TostõesPaula M Alves
Aug 19, 2011·PloS One·Margarida SerraPaula M Alves
Sep 8, 2011·Tissue Engineering. Part C, Methods·Francisco dos SantosJoaquim M S Cabral
Jun 26, 2012·Biotechnology and Bioengineering·Veena WarikooKonstantin Konstantinov
Mar 28, 2013·Biotechnology Advances·Allen Kuan-Liang ChenSteve Kah Weng Oh
Jun 6, 2013·Acta Pharmacologica Sinica·Xin WeiYu-fang Shi
Jul 16, 2013·Trends in Biotechnology·Alois Jungbauer
Jul 31, 2013·Biotechnology and Bioengineering·Ana S SimariaSuzanne S Farid
Nov 16, 2013·Experimental & Molecular Medicine·Matthew B MurphyArnold I Caplan
Jan 15, 2014·Biotechnology and Bioengineering·Francisco Dos SantosJoaquim M S Cabral
Mar 19, 2014·PloS One·Martial HervyZara Melkoumian
Jul 30, 2014·Stem Cell Research & Therapy·Priyanka SwamynathanSudha Balasubramanian
Citations
Mar 1, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·P Gomes-AlvesP M Alves
Aug 21, 2015·Biotechnology Progress·Marcos F Q SousaMargarida Serra
Jan 8, 2016·Journal of Chromatography. a·Bárbara CunhaPaula M Alves
Jun 21, 2015·Immunology Letters·C CapelliM Introna
Aug 17, 2016·Journal of Biotechnology·António M de SoureJoaquim M S Cabral
Sep 22, 2016·Stem Cells and Development·Parvaneh MohammadiNasser Aghdami
Jan 31, 2017·Journal of Biotechnology·Bernardo AbecasisPaula M Alves
Apr 4, 2017·Biotechnology Progress·Nicolas-Julian HilboldHervé Broly
Jun 24, 2016·Tissue Engineering. Part B, Reviews·Toon LambrechtsIoannis Papantoniou
Apr 24, 2019·Nature Biomedical Engineering·Ayesha AijazBiju Parekkadan
Feb 4, 2021·Scientific Reports·Sébastien de BournonvilleGreet Kerckhofs
Jul 21, 2020·Stem Cell Research·Tom A WyrobnikMartina Micheletti
Mar 14, 2021·Biotechnology and Bioengineering·Inês A IsidroMargarida Serra
May 1, 2021·Viruses·Francisca ArezPaula M Alves
May 20, 2021·Stem Cells Translational Medicine·Shangwu ChenKatsuhiko Nakashima
Aug 7, 2021·Bioengineering·Ang-Chen Tsai, Christina A Pacak
Nov 18, 2017·ACS Applied Materials & Interfaces·Martina MiottoChe J Connon
Aug 14, 2021·Biotechnology and Bioengineering·Caroline SionEric Olmos